Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 26/11/2013 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 13/10/2024 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 26/11/2013 |
Alain Parthoens
BRD | Director/Board Member | 66 | 24/10/2018 |
Catherine Boule
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 12.69M | ||
| +8.49% | +20.55% | +70.77% | +110.32% | 68.12B | ||
| +1.25% | +2.44% | +34.27% | +70.43% | 55.18B | ||
| -1.09% | +32.96% | +19.67% | +494.56% | 28.63B | ||
| +10.83% | +18.38% | +56.20% | +6.03% | 23.99B | ||
| +2.72% | +3.41% | -16.11% | -7.96% | 23.53B | ||
| +6.50% | +7.56% | +44.65% | -21.73% | 18.45B | ||
| +6.20% | +11.51% | +33.87% | +693.38% | 16.44B | ||
| -3.88% | +16.98% | +199.30% | +359.77% | 15.83B | ||
| +3.58% | +1.96% | +43.35% | +163.76% | 13.4B | ||
| Average | +3.46% | +11.68% | +54.00% | +207.62% | 29.28B | |
| Weighted average by Cap. | +4.36% | +13.10% | +50.69% | +168.47% |
Employees
31
















